Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 221 participants.
Also called NCT06926842
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 221 participants
- Sponsor
- Registry
-
NCT06926842
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT06926842. Randomized; double masking; primary purpose treatment. Start 2025-04-22 (actual); primary completion 2026-08-13 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)
- Condition
- Overweight
- Condition
- Type 2 Diabetes
- Condition
- Obesity
- Intervention (Drug)
- Petrelintide
- Intervention (Other)
- Placebo
- Lead sponsor
- Zealand Pharma
- Collaborator
- Parexel
Record details
- Record id
cardio:ct-nct06926842- Content hash
bd4afb087f27c01898001cc54b8d018e848b538b721ac73b74753cfac32731af